Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
View Older Stories
-
Carl Icahn Lowers Stake in Clorox Co. (CLX) to 6.89%
-
Form SC 13D/A CLOROX CO /DE/ Filed by: ICAHN CARL C
-
Carl Icahn Lowers Stake in Clorox Co. (CLX) to 8.14%
-
Form SC 13D/A CLOROX CO /DE/ Filed by: ICAHN CARL C
-
Pre-Open Movers 9/26: (MELA) (BRK/B) (NFLX) Higher; (EK) (FSL) (CLX) Lower (more...)
-
Carl Icahn Withdraws Clorox (CLX) Director Slate, Doesn't See Enough Support
-
Carl Icahn withdraws Clorox (CLX) Director slate - 13D
-
Clorox (CLX) Board Comments on Carl Icahn's Press Release, Feels it Undervalues Company
-
Clorox (CLX) Shares Rise as Icahn Issues Statement Saying He Will Buy Co. at $78/Share If Auction Isn't Successful
-
Clorox (CLX) Responds to Icahn Announcement; Committed to Delivering Value to Shareholders
-
Clorox Company (CLX) Releases Statement Regarding Carol Icahns Proposal
-
Icahn to Nominate 11 for Clorox's (CLX) Board of Directors
-
Clorox (CLX) option volume and volatility elevated on wide price movement
-
Clorox (CLX) Investors Taking Profits, Stock Down 2+% Over Last Half Hour
-
Carl Icahn Liquidates Biogen Idec (BIIB), Chesapeake Energy (CHK); Targets Oshkosh (OSK), Forest Labs (FRX) and Commercial Metals (CMC)
-
Clorox (CLX) Rejects Icahn's Offer
-
UBS Maintains a 'Neutral' on Clorox (CLX); More Thoughts on Icahn’s $80 Bid
-
Clorox (CLX) Confirms Receipt of Revised Offer from Icahn, to Review Proposal
-
Icahn Sweetens Bid for Clorox (CLX) to $80/Share; Says 'Let Shareholders Decide'
-
Pre-Open Movers 7/20: (NLC) (ETFC) (AAPL) Higher; (DVAX) (RVBD) (ICGN) Lower (more...)
-
Icahn boosts bid for Clorox (CLX) to $80 per share in cash
-
Clorox (CLX) Formally Rejects Bid from Carl Icahn
-
UBS Maintains a 'Neutral' on Clorox (CLX); Assessing "The Icahn Effect"
-
Top 10 News Items 7/11-7/15: Fed's Latest Minutes Hint at QE3; Google Issues Blowout Q2 Earnings; Moody's, S&P Place US AAA Rating on Watch for Downgrade
-
Carl Icahn Doesn't Want Clorox (CLX), He Wants Procter & Gamble (PG) to Buy It
-
Carl Icahn Coming On CNBC To Discuss Clorox (CLX) Offer
-
Notable Mergers and Acquisitions of the Day 07/151: (CLX) (HK)/(BHP) (ICE)
-
Morning Movers 07/15: (HK) (GOOG) (COG) (CLX) Higher; (FLIR) (PPHM) (DCTH) (QLIK) Lower
-
Pre-Open Movers 7/15: (HK) (GOOG) (CLX) Higher; (FLIR) (SGEN) (RAH) Lower (more...)
-
Clorox (CLX) volatility elevated at 20 into Icahn offering $76.50 per share
-
Clorox (CLX) Confirms $76.50/Share Bid from Icahn, to Review Offer
-
Clorox (CLX) Higher as Icahn Discloses $76.50/Share Takeover Bid
-
Icahn's Icahn Capital Shows New Stake in Amgen (AMGN), Clorox (CLX) and Southern Union (NYSE: SUG); Raises Dynegy (DYN), Lowers Chesapeake (CHK)
-
Icahn Exercises Call Options for 11.5M Shares of Clorox (CLX) at $41/Share
-
Weeden & Co Starts Clorox (CLX) at Hold; Fundamentals Matter, But You Can't Ignore The Icahn In The Room
-
Doug Kass Buys Clorox (CLX) On Sell-Off
-
Canaccord Genuity Morning Coffee on Clorox (CLX): Scrubbing Away Some of the Gains
-
Barclays maintains an 'Equalweight' on Clorox (CLX); Thoughts on Carl Icahn Stake
-
UPDATE - UBS Downgraded Clorox (CLX) to Neutral; No Conviction in Any Activist Angle
-
UBS Downgrades Clorox (CLX) to Neutral
-
Clorox (CLX) options active as shares rally 8% on Icahn reporting a 9.08% stake
-
Clorox (CLX) Shares Rally 6% as Carl Icahn Takes Out New 9.08% Stake
-
Carl Icahn Takes Out 9.08% Stake in Clorox (CLX)
